C4X Discovery Holdings PLC (LSE:C4XD) - Overview

Stock Report

C4X Discovery Holdings PLC C4XD

Last Price
GBX96.00

Day Change
0.00|0.00%

As of 02/12/2016
17:15:05 GMT | GBX
Minimum 15 Minutes Delay.

Last Close96.00p
Day Range95.00 - 95.00
Mkt Cap35.90Mil
52-Wk Range76.00 - 140.90
Yield %0.00
ISINGB00BQQ2RV18
Volume500
P/E-8.91
P/S87.59
P/CF-8.57

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
C4X Discovery Holdings PLC-18.30 
FTSE 100 TR GBP-1.92
 
Financials
201320142015
More ...
Income Statement
Turnover0.740.620.31
Operating Profit-0.59-1.22-3.86
Net Profit-0.48-1.12-3.06
Reported EPS-1.55-3.61-10.77
Balance Sheet
Current Assets1.951.088.57
Non Current Assets0.080.080.14
Total Assets2.031.168.72
Current Liabilities0.130.270.75
Total Liabilities2.272.490.75
Total Equity-0.24-1.337.97
Cash Flow
Operating Cash Flow-0.60-1.11-3.48
Net Change in Cash0.87-0.842.81
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-6.89-18.27--5.25---
2017-7.30-17.37--5.53---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/11/2016PurchaseDr. Clive Dix97.0040,00038,800.00
27/09/2016PurchaseDr. Clive Dix102.00465,686475,000.00
08/12/2015PurchaseDr. Clive Dix77.0050,00038,500.00

Company Profile

C4X Discovery Holdings PLC is a drug development company with an portfolio of novel compounds in development, targeting areas of high unmet medical need with substantial commercial potential.
 

Sector

Biotechnology

Market Position

1174 of 1866 Companies

Index

Outlook

(17/03/2016) "...we believe the group is well positioned to deliver future value to shareholders"

Next Event 02/12/2016

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)-5.5313.1816.37
Div Yld (E)0.004.184.37
PEG (E)0.000.30-0.06
ROCE-48.22205.8080.94
Op Mrgn-1,238.14-19.99-14.75
EPS Grwth0.009.7525.31
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chief Executive OfficerDr. Clive Dix
Chief Financial OfficerMr. Brad Hoy
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.